ALMS (Alumis) EBITDA Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alumis EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Alumis's EBITDA for the three months ended in Sep. 2024 was $-97.59 Mil. Alumis's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, Alumis's EBITDA margin for the quarter that ended in Sep. 2024 was 0.00%.

Alumis EBITDA Margin % Historical Data

The historical data trend for Alumis's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alumis EBITDA Margin % Chart

Alumis Annual Data

Trend

Dec22

Dec23

EBITDA Margin %

Alumis Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBITDA Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Alumis's EBITDA Margin %

For the Biotechnology subindustry, Alumis's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alumis's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alumis's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Alumis's EBITDA Margin % falls into.

Alumis EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Alumis's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-156.89	/	0
	=	%

Alumis's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-97.585	/	0
	=	%

Alumis (NAS:ALMS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Alumis EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Alumis's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alumis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

280 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.alumis.com

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.